GP
GILD icon

GLG Partners’s Gilead Sciences GILD Stock Holding History

GLG Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$834K Buy
+11,646
New +$884K 0.04% 308
2017
Q1 		– Sell
-12,002
Closed -$859K – 473
2016
Q4 		$859K Buy
+12,002
New +$892K 0.03% 301
2016
Q2 		– Sell
-81
Closed -$7K – 445
2016
Q1 		$7K Hold
81
– – ﹤0.01% 400
2015
Q4 		$8K Buy
+81
New +$8.43K ﹤0.01% 440
2015
Q1 		– Sell
-57,784
Closed -$5.45M – 413
2014
Q4 		$5.45M Buy
+57,784
New +$5.98M 0.16% 152
2014
Q3 		– Sell
-182,474
Closed -$15.1M – 444
2014
Q2 		$15.1M Sell
182,474
-515,241
-74% -$40.1M 0.36% 81
2014
Q1 		$49.4M Buy
697,715
+637,458
+1,058% +$50M 0.97% 23
2013
Q4 		$4.53M Sell
60,257
-2,433
-4% -$169K 0.32% 84
2013
Q3 		$3.95M Sell
62,690
-166,240
-73% -$9.94M 0.36% 91
2013
Q2 		$11.7M Buy
+228,930
New +$11.9M 0.45% 72

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GLG Partners's GILD Position: Q4 2017 in Review

GLG Partners opened a new position in Gilead Sciences (GILD) in Q4 2017: 11,646 shares worth $834K. The stake represents 0.04% of the portfolio and ranks #308 among its holdings. This is a return to the name: GLG Partners previously reported a position in GILD as recently as Q4 2016.

GLG Partners first reported a position in GILD in Q2 2013 and has held it in 10 quarters since. The position peaked at $49.4M in Q1 2014. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • GLG Partners held 11,646 shares of Gilead Sciences worth $834K as of Q4 2017.
  • Gilead Sciences was a new GLG Partners position in Q4 2017.
  • Gilead Sciences made up 0.04% of GLG Partners's portfolio in Q4 2017, its #308 holding.
  • GLG Partners first reported a position in Gilead Sciences in Q2 2013 and has held it in 10 quarters since.
  • GLG Partners's Gilead Sciences position peaked at $49.4M in Q1 2014.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.